Disclosures for "Delayed and Deferred Surgery Associated with Cenobamate Use in People with Drug Resistant Focal Epilepsy"
-
The institution of Dr. Pellinen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SK Life Science. The institution of Dr. Pellinen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals.
-
Stefan Sillau has nothing to disclose.
-
Miss Bui has nothing to disclose.
-
Miss Danciutiu has nothing to disclose.
-
The institution of Dr. Kaye has received research support from NeuroPace. The institution of Dr. Kaye has received research support from LivaNova.
-
Dr. Sood has nothing to disclose.
-
Louis Ferrari has received personal compensation for serving as an employee of SK Life science.
-
The institution of Dr. Rosenfeld has received personal compensation in the range of $500,000-$999,999 for serving as a Consultant for SK Life Science. Dr. Rosenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for SK Life Science.
-
Dr. Elder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SK Life Science Inc.. Dr. Elder has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Science Inc.. Dr. Elder has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Neurology and Neuroscience Reports.